Getting Down to Work

Between biomed conferences, Israeli holidays involving barbecuing on the beach and a little sightseeing, we have spent countless hours working on our technologies.  On our first full day in Israel everyone met their Israeli counterparts and saw presentations from the Technion innovator who developed their techs.  From that moment on, we have been fully immersed in every aspect of our technologies: wrapping our minds around the science behind them, researching the potential applications for them, meeting with experts in the field and related fields in which they could be commercialized and of course conceiving of the initial business models for their potential commercialization.

With just one week to immerse ourselves in our technologies, each team presented five potential applications to the class and our instructors.  We were encouraged to move beyond the most obvious applications for our technologies, which means we saw some really outside-the-box ideas for commercial applications for these innovations.

While our instructors, Ze’ev Ganor and Asher Epstein, went easy on us in our first class, they turned on the Israeli charm for our second Thursday night meeting.  The first presentation was interrupted during their first few slides for questions – a sharp contrast from the MBA classes back home where professors patiently await the obligatory “Questions?” slide to tell you how wrong your assumptions are.

Olivia and Lisa presenting their technology

To that end, we have learned a lot during our first full week.  First, you must think outside the box when it comes to entrepreneurship – thinking linearly about applications for a new technology is an easy way to get shot down by a venture capitalist.  Second, understanding the market for a new technological application is not as straightforward as it might at first appear.  Numerous assumptions must often be made (especially when dealing with an innovation that solves a problem in a unique manner), and those assumptions must be supported by logical claims.  Failure to do so is an easy way to ensure tough questions from venture capitalists.  And third, selling a new technology is all about solving a problem.  Convincing your audience of the severity of this problem and how your innovation addresses it better than the competition is the basis of your sales pitch, and you should never lose sight of it.